Oncolo-Co
Board
1 director, since incorporationDirector (not named in the articles)
since 11-01-2022
term without a fixed end
listed in the 2025 annual accounts, filed on 16-10-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “De algemene vergadering die de bestuurder(s) benoemt bepaalt hun aantal, de duur van hun opdracht en, indien er meerdere bestuurders zijn…”deed of 14-01-2022
Mandates through the years
1 name, the dashed line is todayDirector (not named in the articles)
Board
Mandates as a list
-
- Director (not named in the articles), from 11-01-2022 to date
Control
Shares transferred to
Oncolo-Co
This company
Oncolo-Co
Equity €7,616
Profit €2,011 in 2025
Capital
- Contribution
- €12,500
- Shares
- 500 in the deed of 14-01-2022 and 1 later capital increase
- Contribution per share
- €25
- Equity per share
- €15.23 in 2025
- Source
- 2025 annual accounts
Articles of association
deed of 14-01-2022 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Friday of June at 19:00
Shareholders
Share transfer
deed of 18-09-2025 ↗
- to 400 shares
At incorporation
deed of 14-01-2022 ↗
- sole founder · 100% at incorporation
Capital transactions
Capital over time
- 18-09-2025 Converted to available equity · €10,000
- 18-09-2025 Capital increase of €10,000 · 400 new shares · in cash
- 14-01-2022 Incorporation · €2,500 · 100 shares